Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancer, Brazil
Roswell Park Cancer Institute
University of Nebraska
M.D. Anderson Cancer Center
University of Birmingham
Northside Hospital, Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
University of Liege
University of Alabama at Birmingham
Northwell Health
H. Lee Moffitt Cancer Center and Research Institute
Icahn School of Medicine at Mount Sinai
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore